Mesylonib (400 mg) 400mg - 10 Tablets (Imatinib mesylate) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is manufactured ...

(RTTNews) - Inhibikase Therapeutics, Inc. (IKT) announced the completion of its bioequivalence study of IkT-001Pro compared to 400 mg imatinib mesylate. The company said its study met expectations ...

Background and Objective: Imatinib mesylate is the first effective therapy for advanced unresectable gastrointestinal stromal tumours (GIST). Adoption of this therapy in clinical practice is ...

A previous report of a randomized phase II trial of imatinib mesylate in patients with incurable GIST detailed high response rates at both the 400 and the 600 mg/d dose levels. We conducted a ...

In a recent cross-sectional study, Berman et al. found that some patients who were treated with imatinib mesylate had hypophosphatemia, with low-normal serum calcium levels, elevated levels of ...

START-R is an international trial of dasatinib 70 mg twice daily and imatinib mesylate 800 mg/day in patients with chronic-phase CML resistant to prior imatinib mesylate 400-600 mg/day.

Patients with GBM at any recurrence received imatinib mesylate plus hydroxyurea (500 mg twice a day) orally on a continuous, daily schedule. The imatinib mesylate dose was 500 mg twice a day for ...

We describe the case of a 25-year-old woman who received imatinib mesylate (at a daily dose of 400 mg) in a clinical trial for the treatment of aggressive fibromatosis (desmoid tumors) not ...

Two patients who developed refractory sclerodermatous cGVHD following allo-SCT received imatinib mesylate at the dose of 400 mg/day. In both patients, the scleroderma symptoms disappeared within 3 ...

She has been treated with interferon-α for more than 7 years without complete cytogenetic response. Therefore, imatinib mesylate (400 mg/day, p.o.) was started on 1 February 2002.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the launch of Imatinib Mesylate Tablets, USP, a therapeutic equivalent generic version of Gleevec Tablets in the U.S. market approved by ...